NCT02395666 2024-08-06Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in RemissionMilton S. Hershey Medical CenterPhase 2 Completed140 enrolled 14 charts 1 FDA
NCT00939770 2020-06-09Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaChildren's Oncology GroupPhase 1/2 Completed122 enrolled 24 charts 2 FDA